SEC Form 4 · accession 0001209191-16-121690
Cascadian Therapeutics, Inc. · CASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julia Marie Eastland
Officer — CFO & VP Corp. Dev.
Period of report
May 17, 2016
Accepted (ET)
May 19, 2016 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412067
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.15 | May 17, 2016 | A | 300,000 | A | — | May 17, 2024 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The option vests and is exercisable at the rate of 1/4th of the total shares on May 17, 2017 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on May 17, 2020.